Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis.
Psychiatric comorbidity in multiple sclerosis: It's not the genes.
Blood cells and endothelial barrier function.
[Optic neuritis after influenza vaccination in a patient after stem cell transplantation].
Mitochondrial DNA sequence variation in multiple sclerosis.
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis.
Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
Dark microglia: A new phenotype predominantly associated with pathological states.
Nano- and micro-based systems for immunotolerance induction in Multiple Sclerosis.
Translation and Cultural Adaptation of the Multidimensional Scale of Perceived Social Support for Greece.
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
The number of optic neuritis attacks is a potential confounder when comparing patients with NMO vs. controls by voxel-based neuroimaging analysis.
Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.
Bifacial weakness with paresthesias: Serial nerve conduction studies indicate diffuse demyelinating neuropathy.
Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Clinical trials in multiple sclerosis.
A 39 years old woman responding to modafinil with bilateral hypothalamic lesion associated with hyperthermia and hypersomnia: a case report.
[Regarding the article: "multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort"].
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.
Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course.
Mean Contact Quotient Using Electroglottography in Patients With Multiple Sclerosis.
Pages
« first
‹ previous
…
417
418
419
420
421
422
423
424
425
…
next ›
last »